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Non-motor symptoms are now commonly recognized in Parkinson’s disease (PD) and can
include dysautonomia. Impairment of cardiovascular autonomic function can occur at any
stage of PD but is typically prevalent in advanced stages or related to (anti-Parkinsonian)
drugs and can result in atypical blood pressure (BP) readings and related symptoms such
as orthostatic hypotension (OH) and supine hypertension. OH is usually diagnosed with
a head-up-tilt test (HUT) or an (active) standing test (also known as Schellong test) in the
laboratory, but 24 h ambulatory blood pressure monitoring (ABPM) in a home setting may
have several advantages, such as providing an overview of symptoms in daily life alongside
pathophysiology as well as assessment of treatment interventions. This, however, is only
possible if ABPM is administrated correctly and an autonomic protocol (including a diary)
is followed which will be discussed in this review. A 24-h ABPM does not only allow the
detection of OH, if it is present, but also the assessment of cardiovascular autonomic dys-
function during and after various daily stimuli, such as postprandial and alcohol dependent
hypotension, as well as exercise and drug induced hypotension. Furthermore, information
about the circadian rhythm of BP and heart rate (HR) can be obtained and establish whether
or not a patient has a fall of BP at night (i.e., “dipper” vs. non-“dipper”). The information
about nocturnal BP may also allow the investigation or detection of disorders such as sleep
dysfunction, nocturnal movement disorders, and obstructive sleep apnea, which are com-
mon in PD. Additionally, a 24-h ABPM should be conducted to examine the effectiveness
of OH therapy. This review will outline the methodology of 24 h ABPM in PD, summarize
findings of such studies in PD, and briefly consider common daily stimuli that might affect
24 h ABPM.
Keywords: Parkinson’s disease, 24 h ambulatory blood pressure monitoring, orthostatic hypotension, supine
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INTRODUCTION
The motor symptoms of Parkinson’s disease (PD) are widely
known and well studied. In the past 20 years non-motor symp-
toms, which include dysfunction of the autonomic nervous sys-
tem have been increasingly defined and investigated. Non-motor
symptoms are important to the patients and have been found
to have a severe effect on quality of life (Antonini et al., 2012).
A feature of an impaired autonomic nervous system are cardio-
vascular symptoms, such as orthostatic hypotension (OH) and
supine hypertension, which are common (de Visser et al., 2002).
Abbreviations: 24h-BP, 24 hour blood pressure measurement; ABPM, ambulatory
blood pressure measurement; AFT, autonomic function test; BP, blood pressure;
HDRS, Hamilton Rating Scale for Depression; HR, heart rate; HUT, head-up-
tilt; l-DOPA, levodopa; l-OH, late orthostatic hypotension; MAP, mean arterial
pressure; MIBG, (123) I-metaiodobenzylguanidine; MSA, multiple system atrophy;
OH, orthostatic hypotension; OSAS, obstructive sleep apnea syndrome; PAF, pure
autonomic failure; PD, Parkinson’s disease; PPH, postprandial hypotension; PVN,
paraventricular nucleus; SCN, suprachiasmatic nuclei.
Cardiovascular symptoms are, besides infections, the most fre-
quent reason for PD patients being admitted to hospital (Willis
et al., 2012). Autonomic dysfunction has previously been reported
in the advance stage of PD but now it has become clear that auto-
nomic dysfunction can be found even in the early stage of PD
without any medication in a population based cohort (Muller
et al., 2011). Several studies have reported that autonomic fea-
tures may occur before the hallmark motor symptoms of PD
(Abbott et al., 2001; Haensch et al., 2009; Hawkes et al., 2010;
Asahina et al., 2012). Therefore, a correct diagnosis of cardiovas-
cular autonomic function symptoms is crucial in order to manage
them appropriately and possibly even detect PD at a pre-motor
or an earlier motor stage. Several approaches exist to diagnose
cardiovascular autonomic dysfunction, including laboratory and
community-based methods. The aim of this review is to discuss
community-based methods, with a particular focus on 24 h ambu-
latory blood pressure (BP) monitoring in the home setting and
consider its advantages and limitations.
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PARKINSON’S DISEASE AND CARDIOVASCULAR AUTONOMIC
FUNCTION
The autonomic nervous system controls a range of processes vital
for health and wellbeing. It is divided into the parasympathetic
and sympathetic nervous systems which innervate nearly every
organ in the human body (Asahina et al., 2012). Beat-to-beat
control of BP as well as the perfusion of various organs are a
vitally important task of the autonomic nervous system (Iodice
et al., 2010). Physiologic feedback mechanisms via the baroreflex
loops work through cranio-sacral parasympathetic and thoraco-
lumbar sympathetic neural pathways to regulate BP and keep it at
an appropriate level, depending on posture and various situations
(Low and Mathias, 2011). A change in posture always requires an
appropriate autonomic response as due to gravitational stress there
is a shift of 500–700 ml of blood from central compartments to
the legs, causing marked pressure differentials (Hainsworth, 1985;
Mathias, 2002).
A variety of non-motor symptoms in PD are linked to the
impairment of the autonomic nervous system. Symptoms due to
an impaired autonomic nervous system can be caused by aging
processes in addition to the Parkinsonism itself. The Braak staging
hypothesis implicates that in PD, Lewy bodies invade autonomic
centers and the dorsal motor nucleus of the glossopharyngeal and
vagal nerves, the gastrointestinal submucosal plexus and the post-
ganglionic sympathetic nervous system (Asahina et al., 2012). With
increasing age, the sensitivity of the baroreceptors decreases which
can cause a loss of BP control (Haensch and Jörg, 2005). Amongst
others, this is a reason for why cardiovascular disorders increase
with age and often affect PD patients since the majority of them
are older than 50 years (Iodice et al., 2010).
Parkinson’s disease patients often suffer from more than one
symptom caused by dysfunction of the autonomic nervous sys-
tem (Goldstein, 2003). These symptoms can range from gas-
trointestinal, urinary and sexual problems, abnormal sweating,
heat intolerance, and pupillary abnormalities to cardiovascular
symptoms (Goldstein, 2003; Asahina et al., 2012). Cardiovascu-
lar symptoms can manifest themselves in features such as supine
hypertension and various forms of hypotension, such as orthosta-
tic, postprandial, and exercise-induced hypotension. Hypotension,
in its various forms, in PD, can be due to a variety of mechanisms,
including, neurodegenerative processes in the dorsal vagus nerve
(Jost, 2012), decreased post-ganglionic sympathetic innervation
and central lesions in the upper brainstem which affect baroreflex
function (Low et al., 2012).
ORTHOSTATIC HYPOTENSION IN PARKINSON’S DISEASE
Orthostatic hypotension is defined as a decrease of systolic BP by
≥20 mmHg or diastolic BP by≥10 mmHg in 3 min after standing
upright or at a minimum of 60˚ head-up-tilt (HUT) (Lahrmann
et al., 2006; Asahina et al., 2012). In the general population of
the elderly (aged 65 and above) the prevalence of OH has been
estimated to be within a range of 5–36.3% (Alli et al., 1992; Low,
2008), and even up to 50% (Lipsitz, 1983). The wide variety in
prevalence could be caused by diverse factors, such as different
protocols or level of orthostatic stress. But even when the criteria
for OH are met, patients do not necessarily suffer from symp-
toms, because the fall in BP can be tolerated. A reason for this
might be habituation to slowly decreasing levels of BP due to an
improvement of cerebral autoregulation which is known to occur
in patients with autonomic failure (Brooks et al., 1989). This may
explain why many PD patients with OH are asymptomatic (Iodice
et al., 2010).
In patients with OH the ability to increase vascular resistance
when standing is absent or impaired which leads to increased
venous pooling in the lower limbs, reduced stroke volume, and
decreased cardiac output (Smit et al., 1999). This may result in
cerebral, cardiac, renal, muscular hypoperfusion, and cause atten-
dant symptoms,as well as weakness, lethargy, fatigue, falls (Mathias
and Kimber, 1999), and “coat hanger pain” in back and shoulders
(Mathias et al., 1999). Furthermore, in elderly patients who suf-
fer from certain neurological disorders, existing OH can worsen
the prognosis of the disease and increase mortality (Low, 2008).
Speed of positional change, time of day (worse in the morn-
ing), prolonged recumbence, warm environments (hot weather,
central heating, hot bath) causing cutaneous vasodilatation, rais-
ing intrathoracic pressure (micturition, defecation, coughing),
food or alcohol ingestion because of splanchnic vasodilatation,
physical exertion maneuvers which lead to skeletal muscle vasodi-
latation and positions (bending forward, abdominal compression,
leg crossing, squatting, activating calf muscle pump), drugs with
vasoactive properties (including dopaminergic agents) (Iodice
et al., 2010) are all such factors and can lead to possible low BP
readings or OH (see Table 1).
The majority of PD patients suffer from at least one cardio-
vascular symptom. This has been found when looking for entirely
unremarkable results in cardiovascular autonomic function in PD
patients, which were only found in 3 out of 100 patients when
conducting a variety of cardiovascular autonomic function tests
(AFT) (Jost, 1999). However, this finding depends on the defini-
tion of “cardiovascular symptoms” and should be compared with
the prevalence of abnormal cardiovascular findings in healthy
controls. Unlike the general population, where the incidence of
hypertension increases with age, PD patients only rarely suffer
from hypertension and tend to have lower BP readings (Jost, 2012).
Findings about the prevalence of OH in PD vary widely in litera-
ture, but a recent meta-analysis of 25 studies calculated that about
30% of PD patients suffer from OH (Velseboer et al., 2011). There
is also the notion that OH may occur before the hallmark motor
symptoms (Goldstein et al., 2000). Compared to patients who do
not show OH, those with OH were found to be of older age (Lip-
sitz, 1983; Allcock et al., 2004). Consistent with this finding, the
incidence of OH rises with age, disease severity, and (dopamin-
ergic) drug therapy in PD (Goldstein, 2003; Verbaan et al., 2007;
Iodice et al., 2011). A study by Oh et al. (2012) found that OH does
not correlate with motor symptom severity.
Parkinson’s disease patients with OH have impaired
baroreflex-cardiovagal function (Goldstein, 2003) and gener-
ally have a loss of cardiac sympathetic innervation. However
no correlation was found between Cardiac MIBG [(123)I-
metaiodobenzylguanidine)] uptake and OH or other autonomic
findings in PD (Haensch et al., 2009; Oka et al., 2011), suggest-
ing that cardiac sympathetic innervation decreases independently
(Haensch, 2011). Usually patients with OH have low norepineph-
rine levels which suggests that a BP fall could also be caused
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Table 1 | Factors influencing postural (orthostatic) hypotension, adapted from Mathias et al. (2013).
FACTORS INFLUENCING POSTURAL (ORTHOSTATIC) HYPOTENSION
Speed of positional change
Time of day (worse in the morning)
Prolonged recumbency
Warm environment (hot weather, central heating, hot bath)
Raising intrathoracic pressure – micturition, defaecation, or coughing
Food and alcohol ingestion
Physical exertion
Maneuvers and positions (bending forward, abdominal compression, leg crossing, squatting, activating calf muscle pump)*
Drugs with vasoactive properties (including dopaminergic agents)
NON-NEUROGENIC CAUSES OF POSTURAL HYPOTENSION
Low intravascular volume
Blood/plasma loss Hemorrhage, burns, hemodialysis
Fluid/electrolyte Inadequate intake – anorexia nervosa
Fluid loss – vomiting, diarrhea, losses from ileostomy
Renal/endocrine – salt-losing nephropathy, adrenal insufficiency (Addison’s disease), diabetes insipidus, diuretics
Vasodilatation Drugs – glyceryl trinitrate
Alcohol
Heat, pyrexia
Hyperbradykinism
Systemic mastocytosis
Extensive varicose veins
Cardiac impairment
Myocardial Myocarditis
Impaired ventricular filling Atrial myxoma, constrictive pericarditis
Impaired output Aortic stenosis
*These maneuvers usually reduce the postural fall in blood pressure, unlike the others.
by an extra cardiac impairment (Goldstein et al., 2003a). Unlike
in PD, multiple system atrophy (MSA) patients have intact car-
diac sympathetic innervation (Goldstein, 2003). Both groups of
patients (PD and MSA) tend to present with abnormal nocturnal
BP regulation, which is also linked to OH (Iodice et al., 2010).
MSA is a clinically progressive neurodegenerative disorder which
is characterized by Parkinsonism, cerebellar ataxia, and autonomic
dysfunction (Gilman et al., 2008). The symptoms of MSA often
overlap with those of PD, which can make it difficult for doctors
to be able to distinguish between the two conditions. OH is a
cardinal and diagnostic feature of MSA and it is therefore recom-
mended that PD patients showing signs of OH should always, as
a precaution, be tested for MSA (Gilman et al., 2008), in order to
discriminate between the two conditions.
Diagnosis and treatment of OH in PD are important, since OH
could lead to falls and injuries and consequently increased morbid-
ity (Jamnadas-Khoda et al., 2009). The usual approach to achieve
a diagnosis of OH is a standing test (also known as Schellong test)
or passive HUT in an autonomic laboratory. Acquiring a detailed
medical history of a patient in order to exclude OH is essential
but not sufficient by itself. Because typical symptoms connected
to OH, such as light-headedness, dizziness, visual disturbances,
impaired cognition, angina pectoris, etc. (Haensch et al., 2009) are
not specific to OH and might be omitted or not be reported by
some patients suffering from OH (Jamnadas-Khoda et al., 2009).
Sometimes patients might only report increased fatigue which
could also be a sign of OH (Streeten and Anderson, 1998). Inde-
pendently of PD, elderly people often tend to suffer from dizziness
and orthostatic symptoms which may be due to polyneuropathy
that leads to a loss of peripheral nerve fibers (including autonomic
nerve fibers) (Haensch and Jörg, 2005). Therefore, reported dizzi-
ness does not necessarily indicate OH (caused by PD) and should
be further clarified. It is important to always look for other possible
causes of OH as well as (autonomic) polyneuropathy, which could
possibly be found coincidently in PD due to advanced age. But
even though PD patients often suffer from OH symptoms, such as
dizziness and falls, they only very rarely actually lose consciousness
(Jost, 2012).
A standing test, in which BP is measured every minute and a
patient is simply asked to lie still for 10 min and afterward stand
in an upright position for 10 min might be a good alternative to a
HUT for which extensive equipment such as an electronically dri-
ven tilt-table and software are needed. Some even argue that the
standing test is more adequate for measuring OH in PD patients
since it allows for appropriate physiological responses (Jost, 2012).
The standing test might not always be sufficient because even
though it is very specific it has a low sensitivity compared to the
HUT test (Winker et al., 2005). Therefore the guideline developed
by the European Federation of Neurological Sciences (EFNS) rec-
ommends the HUT if the standing test is negative and OH is
suspected (Lahrmann et al., 2006). It might be useful to generally
tilt patients with motor impairments such as PD in order to exclude
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OH. The HUT can be extended to an AFT which also measures
sympathetic vasoconstrictor and parasympathetic responsiveness
using various pressor tests (including isometric exercise, cold pres-
sor, and mental arithmetic tests),Valsalva maneuver, hyperventila-
tion, deep breathing with ECG, and beat-to-beat BP measurement
in order to further establish whether cardiovascular autonomic
function is normal or abnormal (Mathias et al., 2013). OH can
occur after the standard 3 min criteria and this is called late OH
(L-OH) and occurs in about 20% of PD patients (Iodice et al.,
2010). Therefore, some laboratories tilt PD patients over a longer
period of time, such as 20 min, and conduct an additional standing
test in order to compare the results of the two tests and possibly
reveal a masked OH. A third, but not yet very prevalent option to
diagnose OH as well as l-OH is 24 h ambulatory blood pressure
monitoring (ABPM) in the home setting, which allows an investi-
gation of several aspects in daily life and possible factors that may
influence BP, outside of the clinical laboratory over a prolonged
period of time.
TWENTY-FOUR HOUR AMBULATORY BLOOD PRESSURE
MONITORING
CIRCADIAN RHYTHMS
Circadian rhythms in humans are controlled by the suprachias-
matic nuclei (SCN) in the hypothalamus (Buijs et al., 2003; Dibner
et al., 2010; Golombek and Rosenstein, 2010). This endogenous
clock and the secondary clocks in nearly every body cell (Dibner
et al., 2010) are set to an approximate 24 h cycle (Golombek and
Rosenstein, 2010). To maintain this 24 h rhythm and stay synchro-
nized with the environment, it needs input from the outside. This
is achieved by photic cues received by the retina and signaled to
the SCN. These photic cues receive input from the light-dark cycle,
a so called Zeitgeber (“time giver”) signal (Golombek and Rosen-
stein, 2010), which resets the SCN clock (Liu et al., 1997) and is
one way to allow the clock to co-ordinate with the surroundings
(Dibner et al., 2010). The SCN is consequently interconnected
with the paraventricular nucleus (PVN) which is situated in the
hypothalamus and plays a crucial role in coordinating autonomic
function, such as stress, metabolism, and in this context most
importantly, cardiovascular autonomic function (Ferguson et al.,
2008). This way, the SCN proactively influences circadian phys-
iology (Dibner et al., 2010) anticipating daytime and preparing
the body for the upcoming day by raising glucose and cortisol
levels as well as heart rate (HR) (Buijs et al., 2003). Conversely,
melatonin, a hormone that causes drowsiness, is secreted by the
pineal gland and is likewise controlled by the SCN via the PVN
(Isobe and Nishino, 2004). Melatonin levels decrease in the morn-
ing (Buijs et al., 2003), depending on the light-dark cycle (Altun
and Ugur-Altun, 2007).
Blood pressure and HR changes during a 24 h period depend on
the sleep-activity rhythm and on endogenous circadian rhythms
that affect vascular and cardiac functions (Fabbian et al., 2012).
MAP (mean arterial pressure) BP typically declines ∼10–20%
when going from an awake state to being asleep (Snyder et al.,
1964) (see Figure 1). People with such a nocturnal fall of BP are
called “dippers” as opposed to those, whose BP does not fall ade-
quately (see Figure 3) or is even reversed (see Figure 4) who are
called “non-dippers.” Furthermore, the circadian BP rhythm can
FIGURE 1 | Blood Pressure (upper line systolic, lower line
diastolic) and heart rate profiles during 24 h ABPM of a healthy
individual; dipper, showing more than a 10% drop in BP at night
time. Black bar indicates sleep.
exhibit two daytime peaks, one in the morning after getting up
(∼08:00–10:00 h) and one in the evening, roughly 10–12 h later
than the first one (Hermida et al., 2001). Another well recognized
marker of circadian rhythms is the changes in body core temper-
ature, which is also affected by the sleep-wake cycle and displays,
similar to BP and HR, a dip at night and peak in the evening
(Waterhouse et al., 2005).
PD AND CIRCADIAN RHYTHMS
Circadian rhythms are susceptible to a variety of influencing
factors, since they are so delicately organized. It is therefore com-
prehensible that they can also be affected by PD (see Figure 2).
While no direct link between PD and decreased melatonin has
been found, it is known that melatonin levels recede with age
(Altun and Ugur-Altun, 2007), which should therefore also apply
to PD patients. Administering 50 mg of melatonin improved total
night-time sleep in PD patients when compared to a PD placebo
control group (Dowling et al., 2005).
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FIGURE 2 | Blood Pressure (upper line systolic, lower line diastolic) and
heart rate profiles during 24 h ABPM of a PD patient; dipper, showing
more than a 10% drop in BP at night time. Black bar indicates sleep.
Peaks in BP relate to agitation or increased tremor.
Although the feature of acute OH in PD has been well
researched, there are very few studies of the BP/HR circadian
rhythms in PD. Motor activity levels, when measured with an acti-
graph (a non-invasive method of monitoring human rest/activity
cycles) are reversed in PD patients, which means they are higher
at night-time when in bed than during the day (Niwa et al., 2011).
This is concordant with sleep disorders and daytime sleepiness
that are often present in PD (see below) and may also not cre-
ate an ideal foundation for appropriate BP and HR 24 h rhythms.
A study looking at 7 PD and 14 probable MSA patients, found
that core temperature does fall at night in patients with PD, con-
trary to MSA patients whose core temperature does not decrease
nocturnally (Pierangeli et al., 2001).
TWENTY-FOUR HOUR ABPM
Ambulatory BP monitoring using a standard upper arm cuff
method over 24 h may be an extremely useful tool in screening car-
diovascular autonomic function, especially BP variability and OH.
Some may even consider it superior to HUT (Ejaz et al., 2006). The
advantage of ABPM compared to a 3 min HUT is firstly the longer
FIGURE 3 | Blood Pressure (upper line systolic, lower line diastolic) and
heart rate profiles during 24 h ABPM of a PD patient, non-dipper, not
showing a drop (<10%) of BP at night time. Black bar indicates sleep.
time frame it is conducted in, therefore allowing to screen BP not
only at one specific point of a day. It furthermore rules out the
effects of “white coat hypertension” and confounding variables of
artificial clinical surroundings, to which elderly patients are more
prone (Gerstner et al., 2006; Pickering et al., 2008). In a clinical
setting, patients may not have OH because the fall in BP may occur
later (L-OH) or only after daily stimuli such as food ingestion. A
24-h BP recording may therefore be a more economic and simple
way to test for OH compared to routinely tilting patients, which
requires a laboratory and a clinical autonomic scientist or nurse
specialist. ABPM additionally grants insight into a patient’s daily
routine, which allows for investigation of other factors influenc-
ing OH, such as differences in time of day, temperature variations,
raising of intrathoracic pressure (such as coughing or defecation),
exercise, reaction to medication, BP changes after food or alco-
hol ingestion (Iodice et al., 2010). Twenty-four hour ABPM also
allows monitoring of a patient’s circadian rhythm, which reveals
important information about BP characteristics at night, which
can indicate if the patient is a dipper vs. a non-dipper. It has also
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FIGURE 4 | Blood Pressure (upper line systolic, lower line diastolic) and
heart rate profiles during 24 h ABPM of a PD patient with a reversed BP
profile. BP increases at night time in contrast to a dipper. Black bar
indicates sleep.
been reported that ABPM better predicts the risk of morbid events
than BP taken in a clinical setting (Pickering et al., 2005).
Other options to measure BP over a period of 24 h do exist, but
there is no evidence for reasonable use of them in a community-
based setting. One such alternative option is 24 h invasive BP
measurements such as a brachial artery catheter (Imholz et al.,
1993; Omboni et al., 1998). This is naturally the most precise way
of measuring changes in BP, but can only be used in a hospital set-
ting, since it needs to be monitored by health care professionals. A
less invasive alternative would be 24 h recording using digital pho-
toplethysmography using the Penaz method, which continuously
measures beat-to-beat finger BP. This has been found to generate
minimal error compared to brachial artery catheter BP measure-
ments (Omboni et al., 1998). However, to date there is no research
published on its use in a home setting and the equipment is often
cumbersome and very technical. Therefore the well-established
24 h ABPM is recommended since it is easier to use, especially for
older patients. A 24-h ABPM may not only be helpful to find causes
of OH, but it is also of high importance for controlling OH therapy
and assessing the effects of treatment (Iodice et al., 2010). Because
OH may result from medication it is recommended to conduct an
ABPM before and after starting a new therapy (Lahrmann et al.,
2006).
It might be argued though that 24 h ABPM is not sufficient by
itself to diagnose OH, which should always be secured by a HUT or
AFT. ABPM only gives a good overview and might facilitate find-
ings of potential other causes of OH, such as postprandial OH,
but it only directs the doctor in the right direction and findings
should always be confirmed with a HUT, meal-test, exercise test,
etc depending on the circumstances. Another important aspect is
that 24 h ABPM is more widely accessible than a HUT does not
necessarily require referral to a specialist center and can therefore
be conducted by a general practitioner. A combination of a 24-h
ABPM in the home setting potentially followed by a HUT or an
AFT in case of abnormal findings could provide the most thorough
approach (see Chart 2).
ABPMMETHODOLOGY
A well-structured ABPM can provide a range of diverse data about
a patient, but when it is not done correctly, wrong conclusions
may be drawn. A variety of factors should be considered when
administering ABPM with PD patients, which will be discussed
below.
The American Heart Association (AHA) recommends single
BP measurements to be taken every 15–30 min during a 24-h
period (Pickering et al., 2005). However, most published studies
report measurements taken every 15–30 min during daytime and
every 20–60 min at night (Urbina et al., 2008). Even though tak-
ing more regular measurements provides more data, changing the
frequency of measurements at night time should be considered,
since having BP taken at night might disrupt sleep and produce
confounding variables and spurious results when assessing dipper
vs. non-dipper status. But, having enough readings is crucial in
order to effectively evaluate test results. The AHA proposes 50–
100 readings per 24 h period (Pickering et al., 2005) whilst the
British Hypertension Society considers as little as 14 valid mea-
surements during day time and 7 at night time sufficient (O’Brien
et al., 2000). Unsuccessful readings will have to be expected; a rate
of 85% of successful readings is considered suitable for analysis
(Head et al., 2012). A failed reading may be due to movement
during measurement, incorrect cuff placement, weak or irregular
pulse, or several other reasons (Head et al., 2012). The potential
effects of movement in producing failed readings is of particular
concern in PD patients due to tremor. Good compliance is there-
fore crucial and it is necessary to explain why it is important to
keep the arm as still as possible when a measurement is taken.
Ideally an ABPM is conducted at home in a routine daily envi-
ronment instead of a hospital setting. This is due to the fact that
patients spend most of their time in a sitting or lying down posi-
tion when hospitalized, which may not be normal for them. Even
sleeping patterns might be influenced because of increased day-
time rest and nocturnal distractions in a hospital ward setting.
Therefore, measuring BP at home and instructing the patient to
live a regular day as far as possible can provide more reliable data.
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To gain maximum insight into the BP readings, it is important
to provide the patient with an autonomic protocol (including a
diary) in order for them (or a relative/carrier) to record their
activities and symptoms and therefore be able to make a con-
nection between activities and BP changes during episodes. The
format of such diaries used varies considerably. Such diaries
should not only enquire about bed time/time when the patient
fell asleep (including questions about the quality of sleep), time of
awakening and time of medication taken (and what kind of med-
ication) but also provide opportunities for the patient to record
BP when symptomatic and also during various daily activities,
such as sitting and standing throughout the day (i.e., postural
change), before and after food ingestion, and exercise, as well
as during and after medication (Mathias et al., 2013). An auto-
nomic protocol/diary allows for a better screening of OH and
other related features of cardiovascular autonomic dysfunction,
e.g., postprandial hypotension (PPH).
It is essential to record at what time the patient went to bed and
when they woke up, as well as quality of sleep in order to be able
to evaluate the circadian BP pattern and detect if a patient is a dip-
per vs. a non-dipper. Another option is to equip patients with an
accelerometer which measures physical activity and in some, even
the position of the patient (Charbonnier et al., 1999). In addition,
it can give more objective information then a self-kept activity
diary, which is subjective to the patient. A variety of such devices
have been developed, but they are not yet as widely and affordably
accessible as current ABPMs.
A variety factors can worsen and influence OH, many of which
can be detected during a 24 h BP measurement if an autonomic
protocol is kept. Others may only be detected by asking the patient
direct questions and obtaining a good history of past symptoms
(please refer to Table 1).
TWENTY-FOUR HOUR ABPM IN PD
Many 24 h ABPM studies have been performed in PD, but mostly
in a clinical setting, and only rarely in a home setting (see Table 2).
Only a few studies (e.g., Ejaz et al., 2006; Schmidt et al., 2009) used
a diary/autonomic protocol which was given to patients in order
to be able to match BP readings to positions or activities. To date,
no study has had patients perform a standing test or exercise test
during the 24 h ABPM or to ascertain the occurrence of OH in a
home setting.
Most studies investigating 24 h ABPM in PD focus on BP only,
but HR may be of importance as well since it might provide a good
overview of cardiovascular parameters (Mastrocola et al., 1999),
since it has been found to decrease or increase accordingly with
BP readings at night (Schmidt et al., 2009). In 24 h ABPM studies
in PD patients it has been found that the average BP throughout
24 h is typically lower in patients with PD than controls (Brevetti
et al., 1990) and those patients with OH have higher BP readings at
night than those without OH (Senard et al., 1992; Plaschke et al.,
1998) and also have a lower HR variability (Senard et al., 1992).
Nocturnal BP regulation in PD patients was often found to be
pathological because it does not drop or even increases at night in
a 24 h ABPM study (Schmidt et al., 2009). This is consistent with
the findings of another study which showed that all PD patients
tested had PPH and nocturnal hypertension (Ejaz et al., 2006). In a
24 h ABPM study PD patients with hypertension were found to be
more prone to non-dipping than normotensive participants (Oh
et al., 2012). Even anti-hypertensive medication might not have
an effect on the 24 h BP profile of PD patients, since a different
study found no correlation between anti-hypertensive treatment
and non-dipping, e.g., those on hypertensive medication were
not more prone to non-dipping at night (Sommer et al., 2011).
Another study found that PD patients who were treated with flu-
drocortisone have higher BP readings throughout 24 h than those
who were not on fludrocortisone (Hakamaki et al., 1998).
It has been reported that PD patients who have low
BP readings at night and who are dippers (mean± SD
SBP/DBP126± 18/74± 10 mmHg) are more prone to psychosis
than those who have high nocturnal BP (Muhl et al., 1997).
All of the studies described above looking at 24 h BP measure-
ments in PD detected OH in their participants, not necessarily
through the 24 h monitoring itself but through a HUT.
POSTPRANDIAL HYPOTENSION
Postprandial hypotension in PD is known to worsen Parkinson-
ian symptoms such as tremor, bradykinesia, and gait difficulties,
which can be extremely debilitating for patients (Chaudhuri et al.,
1997). During 24 h ABPM, PPH, a symptom often found in PD
(Mehagnoul-Schipper et al., 2001), might become evident. Fur-
thermore, PPH or even postprandial with no fall in BP might
unmask or exacerbate OH in PD patients which can be assessed
during 24 h monitoring by performing a stand test for a period
of 10 min, after a meal and noting any symptoms in the diary.
However, a 24-h BP measurement can only provide preliminary
information on whether PPH may be present; it is not a strong
enough measure to make a diagnosis. Therefore, it should always
be verified with a formal meal challenge in a laboratory setting
(Iodice et al., 2010).
Nozaki et al. (1993) found a prevalence of PPH in PD of 61% in
14 patients. Another, more recent, study investigated PD patients
during a standardized meal and standing test and found that PPH
may even be more common than OH in (elderly) PD patients,
compared to healthy controls (82% PPH in PD, 41% PPH in
healthy controls, compared to 13% OH in PD, 6% in healthy con-
trols) (Mehagnoul-Schipper et al., 2001). The same study showed
that Levodopa did not have an effect on PPH, only disease severity
did (Mehagnoul-Schipper et al., 2001). However, these studies
were all conducted by testing patients in a clinical setting with-
out using 24 h ABPM recording. Ejaz et al. (2006) however found
a PPH prevalence of 100% in 13 PD patients using a 24 h ABPM
with an autonomic protocol in a clinical setting. Alcohol may also
exacerbate postural hypotension (Narkiewicz et al., 2000). A recent
study found that alcohol consumption leads to a decline in the
vasoconstrictor response to orthostatic stimuli (Narkiewicz et al.,
2000). It is therefore crucial not only to examine the BP responses
to food ingestion, but also alcohol intake (Mathias and Kimber,
1999).
A first step to reduce symptoms of PPH might be to ingest
smaller and more frequent meals and less carbohydrates through-
out the day in order to reduce the impact of a big meal while still
eating enough to maintain a healthy weight. As a pharmacological
treatment, octreotide could be considered (Albillos et al., 1994).
www.frontiersin.org May 2013 | Volume 4 | Article 49 | 7
Stuebner et al. Twenty-four hour ABPM in PD
Table 2 | An overview of key findings 24 hr ABPM studies in PD patients.
Study title
(reference)
Type of PD Sample size Setting Technique Treatment % Of
non-dipping
Findings
Brevetti et al.
(1990)
PD 5 PD, 5 control Clinical Ambulatory
intra-arterial BP
measurement
Discontinued
15 days in advance
– Mean 24 h BP was
lower in PD patients
than controls
Senard et al.
(1992)
PD (± OH) 19 with OH, 19
without OH
Clinical ABPM l-DOPA, benserazide;
bromocriptine
94.7%
(PD+OH),
31.6%
(PD−OH)
Average BP at night
was higher and BP
variability was higher
during day than night in
patients with OH
(p<0.05)
Muhl et al.
(1997)
PD (±
psychosis)
32 Clinical ABPM, 15 min
interval
l-DOPA – Psychosis in PD is
correlated with low BP
at night
Hakamaki
et al. (1998)
PD (± OH) 20 PD, 21
controls
– Fludrocortisone 40% (eight
Patients on flu-
drocortisone
were
non-dipper)
PD patients without
fludrocortisone had
lower BP readings
during day and night
than PD on fludro
Plaschke et al.
(1998)
PD (± OH) 13 PD, 11
PD+OH
Clinical ABPM, 20 min
interval during
day, 30 min at
night-time
All treatment
discontinued at least
3 days prior to
testing
– Night-time BP was
higher in 82% of
PD+OH patients,
higher supine BP in
PD+OH than PD
Ejaz et al.
(2006)
PD 13 Clinical ABPM+Diary Levodopa/carbidopa
Selegiline
Gabapentin,
R-Blocker, calcium-
channel-blocker
92.3% postprandial
hypotension, nocturnal
hypertension in 100%
of subjects
Schmidt et al.
(2009)
PD 23 PD, 26
controls (25 PSP,
25 MSA)
Home
setting
ABPM+Diary,
15 min interval
during day, 30 min
at night
Dopamine,
dopamine antagonis,
pramipexole,
pergolid,
Cabergoline,
ropinirol e,a-
dihydroergocryptine,
MAO inhibitor,
COMT inhibitor.
Amantadine
48% (22%
reversed)
Nocturnal BP regulation
was pathological in PD
48%, PSP 40%, MSA
68% vs. Control 8%
Sommer et al.
(2011)
PD 40 Home
setting
ABPM Antihypertensives 88% No correlation between
non-dipping and
anti-hypertensive
treatment; 95% of
PD+OH patients were
non-dipper and 79% of
PD without OH
Oh et al. (2012) Early PD (±
OH)
52 PD, 17
PD+OH
– ABPM Antihypertensives 79.71% The percentage of
patients with
hypertension was
higher in the non-dipper
group
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RESPONSES TO EXERCISE IN PD
Alterations of cardiovascular responses during exercise can be evi-
dent in PD patients, especially if autonomic failure is present, but
research is limited. A recent review (Low et al., 2012) summarized
three papers that reported that PD patients showed reduced eleva-
tions in BP, HR, and noradrenaline when exercising (cycling) com-
pared to age-matched healthy controls (Reuter et al., 1999; Werner
et al., 2006; DiFrancisco-Donoghue et al., 2009). These findings
suggest PD patients show reduced hemodynamic responses when
exercising. Another study found that BP reactivity in healthy indi-
viduals to exercise is highest in the morning, but the reason for
this is not dependent on sleep (Jones et al., 2008). Participants
who slept in the afternoon before being tested showed the same BP
reactivity as those participants who did not sleep in the afternoon
before testing. This suggests that there must be another component
of the circadian rhythm, except sleep, that affects cardiovascular
responses to exercise. PD patients tend to be of advanced age and
are less able to engage in an appropriate amount of cardiovascu-
lar training; the subsequent deconditioning might also potentiate
OH (Jost, 2012). No studies have assessed exercise responses in
PD in the home setting over 24 h. In order to confirm exercise-
induced hypotension or post-exercise OH, an incremental exercise
test preceded and followed by a HUT and/or standing test is the
gold standard.
DRUG INDUCED HYPOTENSION
There are several reasons why OH may occur in PD, but one
crucial factor might be PD medication due to its cardiovascu-
lar side effects. Levodopa is known to have a lowering effect on
BP and may cause or exacerbate OH (Hoehn, 1975; Jamnadas-
Khoda et al., 2009) because it reduces stroke volume, cardiac
output, and systemic vascular resistance (Jamnadas-Khoda et al.,
2009). Any symptoms relating to PD medication can be detected
by conducting a 24 h ABPM when keeping a detailed autonomic
protocol/diary and noting the time of day when medication was
taken.
PD AND BP “DIPPING”
There are few published studies on the presence and extent of non-
dipping in PD. There often is a correlation between the severity of
OH and non-dipping in PD (Senard et al., 1992). A recent study
found that 95% of PD patients who were diagnosed with OH were
non-dippers, compared to 79% (of 40) of PD patients who did not
have OH (Sommer et al., 2011). Furthermore, it has been found
that patients with OH tend to have a higher BP variability then
those without OH (Senard et al., 1992).
Another factor potentially influencing the circadian BP rhythm
is medication. PD patients, who are also diagnosed with OH and
therefore treated with fludrocortisone, tend to have higher BP
readings and are therefore more prone to being non-dippers than
those PD patients who do not take fludrocortisone (Hakamaki
et al., 1998).
Ambulatory blood pressure monitoring findings in PD patients
are in stark contrast to ABPM measurements in patients with
essential hypertension, who only show a reversed circadian rhythm
in 15% of all cases compared to 48–93% (Ejaz et al., 2006; Schmidt
et al., 2009) in PD patients. Nonetheless, there seems to be a
correlation between hypertension and non-dipping in PD, since
Oh et al. (2012) found that in PD patients the percentage of those
with hypertension was higher in the non-dipper group than in
the dipper group. Non-dipping in PD can be caused by a variety
of factors, which are discussed in this review and summarized in
Chart 1.
SUPINE HYPERTENSION
Supine hypertension,which is defined as a systolic BP≥150 mmHg
or diastolic BP ≥90 mmHg (Goldstein et al., 2003b) is quite a
common feature of autonomic failure syndromes (Goldstein et al.,
2003b). This can occur at any time during the day when the patient
is lying down or even semi-recumbent, but is especially prevalent
at night during sleep. These patients will appear as non-dippers
when administering a 24-h ABPM.
It has been suggested that the main reason for supine hyperten-
sion is increased vascular tone in patients with autonomic failure
(Jordan and Biaggioni, 2002). But this can vary in different con-
ditions. In MSA, for example, supine hypertension is proposed to
be caused by residual sympathetic tone unrestrained by the lack of
baroreflex buffering, whilst in PAF the causes of hypertension are
not known but are less dependent on sympathetic tone (Shannon
et al., 2000). Supine hypertension is often linked to OH, and in one
study looking at 24 patients who had PD with OH, all patients had
SH, whilst 27 patients with PD without OH showed a normal BP
profile (Goldstein et al., 2003b). An explanation for these findings
could be that as well as anti-OH therapy with fludrocortisone,
PD treatment with could possibly cause supine hypertension as
a side effect (Goldstein et al., 2003b). But generally it is probably
due to prolonged disease duration and decreased cardiovascular
autonomic function.
It is of high importance to recognize supine hypertension in PD
patients, since nocturnal hypertension is linked to an increased
cardiovascular risk (Sharabi and Goldstein, 2011). As yet, there
has been no study looking at supine hypertension in PD in a home
setting using 24 h ABPM.
PD AND SLEEP
Several factors might lead to a higher BP at night in PD, which
might include problems relating to sleep. A bad quality of sleep
might cause non-dipping. Likewise, it could also be caused by
nocturia (getting up and walking to the bathroom at night) or
nocturnal movement disorders (see below).
It is well known, that up to 90% of PD patients suffer from sleep
disruption (Chaudhuri et al., 2006; Videnovic and Golombek,
2012), this was described as early as in the “Essay on the shaking
palsy” (Parkinson, 1817). Sleep dysfunction predominantly occurs
in the early stages of the disease and may even predate it by several
years (Chaudhuri et al., 2006; Videnovic and Golombek, 2012).
A reason for a high incidence of sleep disorders in PD may be
that dopamine, which is depleted in PD patients, plays a cru-
cial role in sleep regulation and circadian homeostasis (Videnovic
and Golombek, 2012). Dopamine depletion may furthermore lead
to abnormal sleep-wake cycles which may cause extreme day-
time sleepiness (Rye, 2004). It is essential to ask PD patients
detailed questions about their quality of sleep when conduct-
ing a 24-h ABPM, to find possible reasons for non-dipping, but
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CHART 1 | Overview of possible reasons for non-dipping and how to diagnose them.
also to evaluate quality of sleep. An in-depth sleep question-
naire, such as the Pittsburgh sleep quality index (PSQI) (Buysse
et al., 1989), which has been used successfully in large scale PD
studies (Louter et al., 2012), could therefore be used to objec-
tively assess quality of sleep in PD patients that undergo 24 h
ABPM.
While in-depth discussion of sleep disorders in PD is beyond
the scope of this review, it should not be neglected. Readers are
directed to other excellent reviews (Garcia-Borreguero et al., 2003;
Comella, 2007; Peeraully et al., 2012).
DISORDERS OF NOCTURNAL MOVEMENT IN PD
Additional findings that may be made through an ABPM are
disorders of nocturnal movement. These would be reflected in
nocturnal non-dipping, since they often keep patients awake or
do not allow for deep sleep and relaxation. Excessive nocturnal
movement is fairly common in PD (Rye, 2004). These move-
ments are involuntary movements, which are associated with
the extrapyramidal motor system (Rye, 2004). But there may
be tremor, aperiodic and periodic limb movements, as well as
increased phasic and tonic electromyographic activity in REM
sleep, which can often be found in neurodegenerative diseases
involving nuclei of the basal ganglia (Rye, 2004). It has been
reported that roughly a fifth (20.8%) of PD patients suffer from
restless leg syndrome at night which is a comparably high number
in contrast to a prevalence of 8–10% in the aged-matched general
population (Ondo et al., 2002). In addition, REM sleep behavior
disorders have been found to occur in 15–30% of PD patients
when evaluating bed partner accounts of PD patients (Comella
et al., 1998).
PD AND OBSTRUCTIVE SLEEP APNEA SYNDROME
Some papers suggest a connection between PD and obstructive
sleep apnea syndrome (OSAS), with an OSAS prevalence of up to
43% in PD patients (Diederich et al., 2005). This may be related
to impairment of breathing control, impaired respiratory muscle
function due to rigidity and faulty autonomic control of the lungs,
fluctuating muscle functioning, laryngeal spasm associated with
off-states or upper airway dysfunction with tremor-like oscilla-
tions (Hening et al., 2009). However, a more recent study found, in
contrast to earlier investigations, that sleep apnea was less frequent
in PD then in normal controls, suggesting that OSAS may not be
of major clinical relevance in PD patients (Cochen De Cock et al.,
2010). Regardless of the contradicting studies on prevalence in PD,
OSAS might severely affect quality of sleep as well as nocturnal BP
profiles of PD patients (Apps et al., 1985; Trotti, 2010), and there-
fore confound ABPM findings by producing a non-dipper profile,
through sleep disruption and elevations in BP (Silverberg et al.,
2002), which constitute a cardiovascular risk factor.
MANAGEMENT OF SUPINE HYPERTENSION IN PD WITH OH
When a defective circadian rhythm has been detected, therapeu-
tic strategies can be developed, which can include both non-
pharmacological and pharmacological measures. The most obvi-
ous management of high BP at night would be anti-hypertensive
medication but this is not advisable for patients with autonomic
dysfunction or autonomic failure who typically experience or are
at high risk of OH. The EFNS guidelines for the treatment of
supine hypertension recommend conservative measures as used
in the therapy of OH, including raising the head end of the bed
by 20–30 cm, or 10˚, or refraining from taking pressor medication,
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CHART 2 |Twenty-four hour ABPM monitoring flow chart for PD.
such as midodrine, after 6 p.m. (Lahrmann et al., 2006), and to take
fludrocortisone only in the morning and at lunch time. Occasion-
ally, short acting anti-hypertensive medication such as sublingual
nitro-glycerin might be a good choice (Lahrmann et al., 2006).
Other lifestyle changes such as using the effects of the postpran-
dial BP drop may be beneficial as well. Consensus guidelines of
when and how to treat supine hypertension in PD do not yet exist.
The treatment of OH in PD is beyond the scope of this
review. In summary, OH symptoms in PD can in many cases be
ameliorated by non-pharmacological measures that aim to expand
blood volume, increase venous return, and/or reduce/avoid known
risk factors for OH. Usually, a multifaceted approach combining
non-pharmacological and pharmacological treatment is needed.
For further information the reader is directed to other excellent
and extensive publications (Lahrmann et al., 2006; Bannister and
Mathias, 2013).
SUMMARY
Abnormalities in cardiovascular autonomic function such as OH
or supine hypertension, are common complications in PD and
should therefore be diagnosed and treated correctly. Perform-
ing 24 h ABPM in a home setting offers an affordable, widely
available, and valuable procedure to gain an overview of car-
diovascular autonomic dysfunction and its potential causes. It
especially gives insight into BP variations throughout the day,
which may be affected by various factors such as posture, food,
exercise, and medications. Even when a HUT is negative, a 24-
h ABPM may provide important information about how BP
changes during a patient’s routine day and can even unmask
cardiovascular autonomic dysfunction. Furthermore, it can also
provide crucial information about the circadian rhythm of BP
and HR and possible sleep disruption, which are common symp-
toms in PD. The results of a 24-h ABPM rely on the precise
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implementation of the method and it is recommended that the
patient completes a detailed autonomic protocol/diary of their
activities in order to be able to link results, symptoms, and
events that may occur during the day. Research on the use of
24 h ABPM in PD so far is limited but initial findings sug-
gest that an abnormal circadian BP rhythm in PD is common
with an incidence in the range of 40–93%; the mechanisms
of which may be due to autonomic dysfunction/failure, dis-
rupted sleep, supine hypertension, OSAS, or disorders of nocturnal
movement.
In order to summarize what has been described above, the fol-
lowing flowchart provides an overview of possible findings in a
24-h ABPM in PD patients. It furthermore illustrates which diag-
nostic conclusions could be drawn from the findings. This flow
chart cannot cover all possible findings and diagnoses in a 24-h
ABPM, but summarizes what has been described in this review.
It demonstrates the vast possible findings of 24 h ABPM which
highlights the usefulness of administering 24 h ABPM as a regular
screening tool in PD patients to minimize and treat symptoms of
autonomic nervous system dysfunction.
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